GKB Ophthalmics Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Krishna Gopal Gupta & Sons (HUF), was filed 30 Jun 2026.
GKB Ophthalmics: what insiders have been doing
GKB Ophthalmics is a listed company. Filings by its managers are published through SEBI (PIT + SAST). In the past year (8 November 2025 to 8 November 2026), 5 filings came from 1 insider.
Every open-market trade in the period is a purchase: 5 purchases worth €599, from 1 insider, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The largest single trade was a purchase of €203 by Krishna Gopal Gupta & Sons (HUF), published on 30 June 2026, equal to 0.0067% of the market capitalisation. Those buying include 1 major shareholder.
The last insider purchase was made public on 30 June 2026, 131 days ago. Publication is fast: at least half of the trades appear on SEBI (PIT + SAST) on the same day. The shorter that gap, the sooner other investors can see what insiders have done.
With 5 filings in twelve months, the company is more active than the median of 4 filings across the 1,985 companies we follow on the same exchange. The full history, which starts in 2026, counts 5 purchases against no sales.
These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- +2.5%Entry ₹62.14 · Close at T+90 ₹63.68
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 316 shares@ ₹63.600.0061% mcap31.0% of flowEquity SharesMarket PurchaseSEBI:91995583377cc8003ffbf8e20f2fbca609cf33e8Canonical exit: 28 Sept 2026 (T+90)
- 50 shares@ ₹64.200.0010% mcap5.0% of flowEquity SharesMarket PurchaseSEBI:24c1a17c17f241b4ce015d536e909a7814640109Canonical exit: 28 Sept 2026 (T+90)
- 147 shares@ ₹62.700.0028% mcap14.2% of flowEquity SharesMarket PurchaseSEBI:dab4ffef86fa52b243c085ebf339bb9bd9670ad1Canonical exit: 28 Sept 2026 (T+90)
- 343 shares@ ₹64.100.0067% mcap33.9% of flowEquity SharesMarket PurchaseSEBI:f14b7b3289e4e775f46a0702bcc2eb691d3b6f64Canonical exit: 28 Sept 2026 (T+90)
- 160 shares@ ₹64.200.0031% mcap15.9% of flowEquity SharesMarket PurchaseSEBI:52ff4fb63afd4df42bbce95069c002e1123956b6Canonical exit: 28 Sept 2026 (T+90)
5 of 5 declarations
About GKB Ophthalmics
GKB Ophthalmics is a company focused on the development and manufacturing of ophthalmic products. It operates in the XBOM market.